ArticleJournal of robotic surgery2026
Hinotori vs. da Vinci: a multi-institutional study on robot-assisted radical prostatectomy outcomes.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To compare perioperative, functional, and oncological outcomes of robot-assisted radical prostatectomy (RARP) performed using the hinotori Surgical System and the da Vinci Surgical System in a multi-institutional real-world setting. We retrospectively analyzed 2,066 patients who underwent RARP at 13 institutions. To ensure comparability, 1:2 propensity score matching was performed based on baseline clinicopathological variables, resulting in matched cohorts of 273 patients in the hinotori group and 546 in the da Vinci group. Perioperative, functional (urinary continence), and oncological (biochemical recurrence) outcomes were evaluated. Total operative time and console time were longer in the hinotori group than in the da Vinci group. In contrast, estimated blood loss, postoperative complications, and positive surgical margin rates were comparable between the two groups. No significant differences were observed in time to recovery of urinary continence within the first postoperative year or in biochemical recurrence-free survival. The 3-year biochemical recurrence-free survival rates were 96% in the hinotori group and 95% in the da Vinci group. Within the hinotori cohort, console time was significantly shorter in the later period of system adoption, suggesting a learning effect associated with accumulated experience. In this first multi-institutional comparison, hinotori-assisted RARP achieved perioperative, functional, and oncological outcomes comparable to those of the da Vinci, with operative efficiency improving as experience accumulated.
Indexed as
Identifiers
42010030What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.